Fidelity’s Custody Business Around Bitcoin ‘Incredibly Successful’: Johnson
Bloomberg
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push
(Bloomberg) — AstraZeneca Plc, one of the drugmakers leading the fight against Covid-19, highlighted where its growth will come from after the pandemic with a $39 billion deal for rare-disease specialist Alexion Pharmaceuticals Inc.The proposed cash-and-stock acquisition will add